102 related articles for article (PubMed ID: 9409225)
1. Beneficial effects of alcohol withdrawal on LDL particle size distribution and oxidative susceptibility in subjects with alcohol-induced hypertriglyceridemia.
Ayaori M; Ishikawa T; Yoshida H; Suzukawa M; Nishiwaki M; Shige H; Ito T; Nakajima K; Higashi K; Yonemura A; Nakamura H
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2540-7. PubMed ID: 9409225
[TBL] [Abstract][Full Text] [Related]
2. Eicosapentaenoic acid improves endothelial function in hypertriglyceridemic subjects despite increased lipid oxidizability.
Okumura T; Fujioka Y; Morimoto S; Tsuboi S; Masai M; Tsujino T; Ohyanagi M; Iwasaki T
Am J Med Sci; 2002 Nov; 324(5):247-53. PubMed ID: 12449445
[TBL] [Abstract][Full Text] [Related]
3. Postprandial lipoprotein responses in hypertriglyceridemic subjects with and without cardiovascular disease.
Hughes TA; Elam MB; Applegate WB; Bond MG; Hughes SM; Wang X; Tolley EA; Bittle JB; Stentz FB; Kang ES
Metabolism; 1995 Aug; 44(8):1082-98. PubMed ID: 7637651
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B.
Chait A; Brazg RL; Tribble DL; Krauss RM
Am J Med; 1993 Apr; 94(4):350-6. PubMed ID: 8475928
[TBL] [Abstract][Full Text] [Related]
5. Lipid compositional differences of small, dense low-density lipoprotein particle influence its oxidative susceptibility: possible implication of increased risk of coronary artery disease in subjects with phenotype B.
Ohmura H; Mokuno H; Sawano M; Hatsumi C; Mitsugi Y; Watanabe Y; Daida H; Yamaguchi H
Metabolism; 2002 Sep; 51(9):1081-7. PubMed ID: 12200749
[TBL] [Abstract][Full Text] [Related]
6. Effects of alcohol consumption on antioxidant content and susceptibility of low-density lipoprotein to oxidative modification.
Suzukawa M; Ishikawa T; Yoshida H; Hosoai K; Nishio E; Yamashita T; Nakamura H; Hashizume N; Suzuki K
J Am Coll Nutr; 1994 Jun; 13(3):237-42. PubMed ID: 8077571
[TBL] [Abstract][Full Text] [Related]
7. The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia.
Stalenhoef AF; de Graaf J; Wittekoek ME; Bredie SJ; Demacker PN; Kastelein JJ
Atherosclerosis; 2000 Nov; 153(1):129-38. PubMed ID: 11058707
[TBL] [Abstract][Full Text] [Related]
8. Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease.
Karpe F; Hellénius ML; Hamsten A
Metabolism; 1999 Mar; 48(3):301-7. PubMed ID: 10094104
[TBL] [Abstract][Full Text] [Related]
9. [Effects of plasma very low density lipoprotein, low density lipoprotein and high density lipoprotein on platelet aggregation in endogenous hypertriglyceridemia].
Deng Z; Liu B; Zhou J; Zhang Z; Liu Y; Bai H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 34(4):704-7. PubMed ID: 14619587
[TBL] [Abstract][Full Text] [Related]
10. Vitamin E/lipid peroxide ratio and susceptibility of LDL to oxidative modification in non-insulin-dependent diabetes mellitus.
Yoshida H; Ishikawa T; Nakamura H
Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1438-46. PubMed ID: 9261278
[TBL] [Abstract][Full Text] [Related]
11. Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance.
Tan KC; Cooper MB; Ling KL; Griffin BA; Freeman DJ; Packard CJ; Shepherd J; Hales CN; Betteridge DJ
Atherosclerosis; 1995 Mar; 113(2):273-87. PubMed ID: 7605366
[TBL] [Abstract][Full Text] [Related]
12. Phenotype-dependent and -independent actions of rosuvastatin on atherogenic lipoprotein subfractions in hyperlipidaemia.
Caslake MJ; Stewart G; Day SP; Daly E; McTaggart F; Chapman MJ; Durrington P; Laggner P; Mackness M; Pears J; Packard CJ
Atherosclerosis; 2003 Dec; 171(2):245-53. PubMed ID: 14644393
[TBL] [Abstract][Full Text] [Related]
13. Uptake of type III hypertriglyceridemic VLDL by macrophages is enhanced by oxidation, especially after remnant formation.
Whitman SC; Miller DB; Wolfe BM; Hegele RA; Huff MW
Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1707-15. PubMed ID: 9327767
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
[TBL] [Abstract][Full Text] [Related]
15. Oxidative modification of lipoproteins in hypertriglyceridemic patients and hypercholesterolemic rabbits in vivo.
Liu BW; Jiang Y; Fu MD; Liu Y; Fan P
Mol Cell Biochem; 2000 Apr; 207(1-2):131-5. PubMed ID: 10888238
[TBL] [Abstract][Full Text] [Related]
16. Hypertriglyceridemic subjects exhibit an accumulation of small dense chylomicron particles in the fasting state.
Irawati D; Mamo JC; Soares MJ; Slivkoff-Clark KM; James AP
Atherosclerosis; 2015 Nov; 243(1):236-41. PubMed ID: 26407667
[TBL] [Abstract][Full Text] [Related]
17. Identification of multiple dense LDL subfractions with enhanced susceptibility to in vitro oxidation among hypertriglyceridemic subjects. Normalization after clofibrate treatment.
de Graaf J; Hendriks JC; Demacker PN; Stalenhoef AF
Arterioscler Thromb; 1993 May; 13(5):712-9. PubMed ID: 8485123
[TBL] [Abstract][Full Text] [Related]
18. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia.
Karpe F; Steiner G; Olivecrona T; Carlson LA; Hamsten A
J Clin Invest; 1993 Mar; 91(3):748-58. PubMed ID: 8450056
[TBL] [Abstract][Full Text] [Related]
20. Atorvastatin treatment beneficially alters the lipoprotein profile and increases low-density lipoprotein particle diameter in patients with combined dyslipidemia and impaired fasting glucose/type 2 diabetes.
Pontrelli L; Parris W; Adeli K; Cheung RC
Metabolism; 2002 Mar; 51(3):334-42. PubMed ID: 11887170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
